Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CNSI at UCLA to Host Forum on New Technologies for Brain, Spinal Trauma

-- Scientists, tech leaders, educators, actor Dustin Hoffman to attend 5th annual world congress on brain-mapping, intraoperative surgery --

CNSI at UCLA to Host Forum on New Technologies for Brain, Spinal Trauma

LOS ANGELES, CA | Posted on August 14th, 2008

The California NanoSystems Institute (CNSI) at UCLA today announced that it will host an international forum featuring some of the world's most innovative scientists and technology leaders at the vanguard of treatments for brain and spinal cord injuries and diseases.

The fifth annual World Congress of the International Brain Mapping and Intraoperative Surgical Planning Society (IBMISPS), to be held at the CNSI on the UCLA campus from Tuesday, Aug. 26, to Friday, Aug. 29, will highlight new treatments based on innovations in intraoperative surgical planning and brain-mapping. The advances that will be discussed underscore the benefits of a multidisciplinary approach to bridging science and technology in order to accelerate medical breakthroughs.

"Many of the technologies that are influencing medicine as it relates to the brain and spinal cord involve nanotechnology, and hosting this conference at CNSI is an opportunity to stimulate discussion and fortify our relationship with a cutting-edge field," said the CNSI's interim director, Leonard H. Rome. "CNSI has been built entirely on the spirit of multidisciplinary cooperation among engineers, clinicians and basic scientists. We share this vision with IBMISPS and are delighted to host this event to spur a lively and thought-provoking discussion."

During the four-day meeting, scientists and physicians will illustrate and debate how the fields of science and technology converge in medicine and ultimately serve to enhance the lives of people who suffer from trauma to the brain and spinal cord. The meeting will explore post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), two of the most prevalent injuries experienced by veterans returning from Iraq and Afghanistan.

"PTSD and TBI are prescient topics, as more and more veterans return from war in need of effective treatments," said Dr. Babak Kateb, founding executive director and chairman of the board of directors of the IBMISPS. "Officials from the Department of Defense, which has earmarked $300 million this summer for PTSD and TBI research, will be exchanging ideas and comparing notes with world-class scientists and surgeons to explore unconventional approaches to these significant health care issues."

A guest appearance will be made by two-time Academy Award winner Dustin Hoffman, who co-starred in the 1988 film "Rain Man" about an autistic savant. Hoffman played Raymond Babbitt, who was based in part on Kim Peek, a savant whose eidetic, or photographic, memory and developmental disabilities were the possible result of congenital brain abnormalities. Hoffman will receive the 2008 IBMISPS Beacon Award for Raising Awareness about Neurological Disease.

One of the major challenges of the new millennium is translating the advances made in other fields of science and technology into medicine. The IBMISPS is committed to partnering with institutions, government agencies, policymakers and industry leaders to facilitate the translation of cutting-edge science and technology from other disciplines into medicine.

"Improved neurosurgical techniques and tools for neuroimaging and brain mapping are required for treating medical impossibilities such as neurodegenerative diseases and inoperable brain cancer," said Dr. Patrick Soon-Shiong, chairman and chief executive officer of Abraxis BioScience, which is co-sponsoring the forum. "The discovery process towards break-through therapies will be significantly accelerated through multidisciplinary research and innovation. Thus it is my sincere hope that the interaction of world-class scientists gathered at this congress will expand the realm of possibilities for each researcher and promote cross-disciplinary collaboration."

Soon-Shiong, one of the keynote speakers at this year's congress, is also a member of the CNSI Advisory and Oversight Board.

Other keynote speakers include Leonard H. Rome, interim director of the CNSI and senior associate dean of research at the David Geffen School of Medicine at UCLA; Dr. Ron Kikinis, founding director of the Surgical Planning Laboratory and director of the National Center for Image Guided Therapy at the Harvard University Medical School; Dr. Ron Von Jako, chief medical officer and surgical development leader at GE Healthcare Surgery; Dr. Christian Macedonia, chief of research operations at the U.S. Army's Telemedicine and Advanced Technology Research Center; California state Sen. Mark Ridley Thomas; and Herb Schultz, senior health policy advisor for the California Office of the Governor.

The International Brain Mapping and Intraoperative Surgical Planning Society is a nonprofit association organized for the purpose of encouraging basic and clinical scientists who are interested or active in areas of brain-mapping and intraoperative surgical planning to share their findings with other physicians and scientists across the disciplines, including neurosurgery, radiology, neurology, biotechnology, anthropology and neuroscience. The association also promotes the public welfare through the advancement of intraoperative surgical planning and brain-mapping, a commitment to excellence in education, and a dedication to research and scientific discovery. The association's mission will be achieved through multidisciplinary collaboration involving government agencies, patient advocacy groups, educational institutes and private sector industry brought together in order to address issues and problems related to brain-mapping and intraoperative surgical planning and to implement new technologies to benefit patient care. For additional information, visit


About California NanoSystems Institute at UCLA
The California NanoSystems Institute at UCLA is an integrated research center operating jointly at UCLA and the University of California, Santa Barbara, whose mission is to foster interdisciplinary collaborations for discoveries in nanosystems and nanotechnology; train the next generation of scientists, educators and technology leaders; and facilitate partnerships with industry, fueling economic development and promoting the social well-being of California, the United States and the world. The CNSI was established in 2000 with $100 million from the state of California and an additional $250 million in federal research grants and industry funding. At the institute, scientists in the areas of biology, chemistry, biochemistry, physics, mathematics, computational science and engineering are measuring, modifying and manipulating the building blocks of our world — atoms and molecules. These scientists benefit from an integrated laboratory culture enabling them to conduct dynamic research at the nanoscale, leading to significant breakthroughs in the areas of health, energy, the environment and information technology. For more information, visit

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE), which is based on the company's proprietary tumor targeting technology known as the nab™ platform. The first FDA approved product to use this nab™ platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit

For more information, please click here

The California NanoSystems Institute at UCLA
Jennifer Marcus, 310-267-4838

PondelWilkinson Inc.
Ron Neal

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanosciences: Genes on the rack October 21st, 2016

Physicists use lasers to capture first snapshots of rapid chemical bonds breaking October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

New perovskite solar cell design could outperform existing commercial technologies: Stanford, Oxford team creates high-efficiency tandem cells October 21st, 2016


Nanosciences: Genes on the rack October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

Tiny gold particles could be the key to developing a treatment for pancreatic cancer October 19th, 2016

Highly conductive and pure gold nanostructures grown by electron beam induced deposition October 17th, 2016


Nanosciences: Genes on the rack October 21st, 2016

Physicists use lasers to capture first snapshots of rapid chemical bonds breaking October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

New perovskite solar cell design could outperform existing commercial technologies: Stanford, Oxford team creates high-efficiency tandem cells October 21st, 2016


Leti Scientists Participating in Sessions on Med Tech, Automotive Technologies, MEMS, Si-photonics and Lithography at SEMICON Europa: Teams also Will Demonstrate Technology Advances in Telecom, Data Fusion, Energy, Silicon Photonics and 3D Integration October 18th, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Pokhara (Nepal) all set to host KaSAM-2016: An International Scientific Meeting on Advanced Materials October 15th, 2016

MEMS & Sensors Industry Group Reveals Tech Showcase Finalists --MSIG hosts competition for unique MEMS/sensors demos at MEMS & Sensors Executive Congress, 11/10/16 in Scottsdale, AZ October 11th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project